- Akbank reported a net income of 11.1 billion liras for the second quarter of 2025, which surpassed analysts’ estimates of 10.6 billion liras.
- This net income shows a year-over-year increase of 1.6%.
- The bank achieved a net interest income of 18.6 billion liras, reflecting an 8.5% increase compared to the previous year.
- Net fee and commission income saw significant growth, reaching 25.8 billion liras, up by 61% year-over-year.
- Investment analysts have rated the bank’s stock with 15 buy recommendations and 8 hold recommendations, with no sell recommendations.
A look at Akbank TAS Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts reviewing the Smartkarma Smart Scores for Akbank TAS have assigned the company a generally positive outlook. With a strong Value score of 4, Akbank TAS is seen as offering good value potential. The Dividend score of 4 indicates a promising dividend outlook, appealing to income-focused investors. Additionally, the company has received a Momentum score of 4, suggesting positive price momentum in the market.
Although Growth and Resilience scores are slightly lower at 3, Akbank TAS still shows potential for growth and resilience in the long term. As a retail and corporate banking services provider known for offering a range of financial products and services, including consumer credits, credit cards, wealth management, and insurance, Akbank TAS continues to attract deposits and expand its presence both in Turkey and overseas, positioning it well for future opportunities.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
